Expression of neuroendocrine markers predicts increased survival in triple-negative breast cancer patients

BackgroundThe significance of neuroendocrine (NE) markers in triple-negative breast cancer (TNBC) patients has not been investigated. This study aims to clarify the incidence and prognostic significance of NE marker expression in TNBC, determine its association with other clinicopathological paramet...

Full description

Bibliographic Details
Published in:	Frontiers in Endocrinology
Main Authors:	Chuan Xia, Songjie Shen, Junyi Pang, Longyun Chen, Jie Yan, Zhiyong Liang, Xinyu Ren
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-12-01
Subjects:	triple-negative breast cancer synaptophysin chromogranin A neuroendocrine markers prognosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1205631/full

Similar Items

Neuroendocrine Breast Carcinoma: Interesting Images of an Underdiagnosed Entity
by: Christoforos Kosmidis, et al.
Published: (2024-05-01)

Is There a Relationship between the Staining Pattern of Classical Neuroendocrine Markers and Clinicopathological Findings in Neuroendocrine Tumors of the Appendix?
by: Merve CİN, et al.
Published: (2025-01-01)

Primary giant hepatic neuroendocrine neoplasms in a young adult: case report and literature review
by: Xue Luo, et al.
Published: (2025-07-01)

A rare case of prostate neuroendocrine tumor: A case report
by: Shunxing Teh, et al.
Published: (2022-10-01)

Pure small cell neuroendocrine carcinoma of urinary bladder: A case report
by: Abbas Eshraghi, et al.
Published: (2022-08-01)

Comparison of insulinoma-associated protein 1 (INSM1) with traditional neuroendocrine markers in gastrointestinal and pancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs)
by: Rui Gao, et al.
Published: (2024-10-01)

A Case of Sinonasal Neuroendocrine Tumour: Diagnostic and Therapuetic Challenge
by: Gundappa Mahajan, et al.
Published: (2025-07-01)

Is there any neuroendocrine differentiation in squamous cell carcinoma of larynx?
by: M. Kürşat Gökcan, et al.
Published: (2010-03-01)

Significance of chromogranin A and synaptophysin in pancreatic neuroendocrine tumors
by: Tatsuo Tomita
Published: (2020-08-01)

Primary breast neuroendocrine carcinoma: a case report and literature review
by: CHEN Jiaying, et al.
Published: (2024-03-01)

Can INSM1 and Phox2B be an Alternative to Conventional Neuroendocrine Markers in the Diagnosis of Pancreatic Solid Pseudopapillary Neoplasia and Neuroendocrine Tumors?
by: Merve Cin, et al.
Published: (2025-05-01)

Neuroendocrine Breast Cancer. Clinical Observation. Personalized Approach
by: Sh. Kh. Gantsev, et al.
Published: (2021-05-01)

The Application of ImmunohistoChemical Markers for Diagnosis, Classification and Grading of Neuroendocrine Tumors
by: Kaswer Musa Al-Turaihi, et al.
Published: (2014-12-01)

Clinico-epidemiological Profile of Incidentally Detected Gastrointestinal Neuroendocrine Tumours on Gastrointestinal Endoscopy: A Retrospective Study
by: AK Koushik, et al.
Published: (2023-04-01)

Neuroendocrine cancer of the prostate. Two case reports
by: Tamás Kullmann, et al.
Published: (2022-03-01)

Neuroendocrine and squamous cell phenotypes of NUT carcinoma are potential diagnostic pitfalls that discriminating it from mimickers, such as small cell and squamous cell carcinoma
by: Hironori Ninomiya, et al.
Published: (2024-02-01)

Searching for New Biomarkers of Neuroendocrine Tumors: A Comparative Analysis of Chromogranin A and Inflammatory Cytokines in Patients with Neuroendocrine Tumors
by: Marlena Budek, et al.
Published: (2024-10-01)

Serum Chromogranin Level in Gastrointestinal, Pancreas, and Liver Neuroendocrine Tumors: A Brief Report
by: Mahboubeh Azema, et al.
Published: (2022-01-01)

Histological characterisation and prognostic evaluation of 62 gastric neuroendocrine carcinomas
by: Yujie Deng, et al.
Published: (2016-09-01)

Сравнительное исследование хромогранина А и хромогранина В у больных с нейроэндокринными опухолями желудка и поджелудочной железы
by: N. V. Lyubimova, et al.
Published: (2021-11-01)

Chromogranin A: As A Tumor Marker for Neuroendocrine Tumors Diagnosis, Follow-up & Its Correlation with Response to Somatostatin Analogues
by: Manwar A. Mohammed AL-Naqqash
Published: (2016-01-01)

The Expression of Neuroendocrine Markers in a Small Subset of Ameloblastoma with Implications of Clusterin
by: Hiromasa Hasegawa, et al.
Published: (2025-02-01)

The Clinico-epidemiologic Characteristics of Iraqi Patients with Neuroendocrine Tumors and Their Response to Long Acting Octreotide
by: Marwah K. Abdulfattah, et al.
Published: (2016-01-01)

Case Report: Neuroendocrine carcinoma of the breast: a review of the literature and illustration of six cases
by: Nazire E. Albayrak
Published: (2025-08-01)

Neuroendocrine tumors of the vagina
by: S. O. Nikogosyan, et al.
Published: (2015-09-01)

Predictors of Outcomes in Gastric Neuroendocrine Tumors: A Retrospective Cohort
by: Raquel Ortigão, et al.
Published: (2023-07-01)

Neuroendocrine differentiation as a survival prognostic factor in advanced non-small cell lung cancer
by: Petrović Marina, et al.
Published: (2007-01-01)

Prognostic significance of the aberrant expression of neuroendocrine markers in melanomas
by: Yan Wu, et al.
Published: (2021-08-01)

Editorial: Neuroendocrine tumors of the gastrointestinal tract, liver, and pancreas: current management and treatment strategies
by: Alexandros Giakoustidis, et al.
Published: (2023-05-01)

The neuroendocrine markers assay and the glycemia profile in patients with neuroendocrine tumors under octreotide therapy: a 2 years study / Determinarea markerilor neuroendocrini şi a profilului glicemic la pacienţii cu tumori neuroendocrine în tratament cu octreotid
by: Poiană Cătălina, et al.
Published: (2014-09-01)

Neuroendocrine gene subsets are uniquely dysregulated in prostate adenocarcinoma
by: Nicole M. Naranjo, et al.
Published: (2024-12-01)

The prognostic value of stem cell markers in triple-negative breast cancer
by: Szintia Almási, et al.
Published: (2023-12-01)

Neuroendocrine tumors: aspects of diagnosis (literature review)
by: A.M. Kvachenyuk, et al.
Published: (2020-02-01)

Synaptophysin Immunoreactivity as Marker for Fetal Hippocampal and Cortical Development
by: J Gordon Millichap
Published: (2010-06-01)

High expression of insulinoma‐associated protein 1 (INSM1) distinguishes colorectal mixed and pure neuroendocrine carcinomas from conventional adenocarcinomas with diffuse expression of synaptophysin
by: Anne‐Sophie Litmeyer, et al.
Published: (2023-11-01)

Performance Evaluation of the KRYPTOR Compact PLUS Analyzer-Based B.R.A.H.M.S. CgA Ⅱ KRYPTOR Assay for Chromogranin A Measurement
by: Yu Jeong Choi, et al.
Published: (2021-12-01)

Duodenal neuroendocrine cells and neuromedin U in subjects with obesity: Relationship with type 2 diabetes and glucose homeostasis
by: Hassan Bur, et al.
Published: (2025-08-01)

Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia
by: Marco Santoro, et al.
Published: (2022-08-01)

CHROMOGRANIN-A IN THE DIAGNOSIS OF PROSTATE CANCER
by: A. V. Sivkov, et al.
Published: (2015-04-01)

Exploring Chromogranin A (CgA) as a Diagnostic Marker in Hypothermia-Related Deaths: Two Case Studies and a Literature Review
by: Luca Tomassini, et al.
Published: (2025-06-01)